High Throughput Screening in the European Lead Factory
Poster Sep 23, 2014
S.P. van Helden, W.H. Rutjes, C.A.A. van Boeckel and J.H.M. van den Broek
The European Lead Factory is a pan-European platform for drug discovery, supported by IMI, which was set to give a major boost to drug research in Europe. Comprising a collection of half a million compounds and a screening centre, the European Lead Factory will offer both researchers in academia and SMEs an unprecedented opportunity to advance medical research and develop new medicines.
High Throughput Screening for the European Lead Factory is performed at the Pivot Park Screening Centre in Oss, The Netherlands. In the first year of the European Lead Factory state-of-the-art systems have been made operational and efficient procedures have been implemented. The success of the European Lead Factory is witnessed by the completion of more than 10 screening campaigns in the first year and by the handing over of qualified hit lists to the target owners.
This paper describes workflows that have been implemented at the screening centre of the European Lead Factory and presents screening statistics on the first 18 months of operation. The workflows include intake of assays from public parties, miniaturization to 1536 format, screening and cherry picking using acoustic dispensing. Currently already more than 25 high quality programmes have been selected covering a wide range of disease areas. The first data of this open innovation infrastructure will be presented underlining the importance of closing the gap between early target discovery research (academia/SME) and clinical phase’s development (Big Pharma).
Extracorporeal shockwave therapy accelerates motor axon regeneration despite a phenotypically mismatched environmentPoster
A femoral nerve defect model was adapted for the evaluation of proregenerative effects of extracorporeal shockwave therapy (ESWT). Functional evaluation, histology and qRT-PCR data show differences between sensory and motor-derived nerve transplants and a pro-regenerative effect of ESWT. These data provide evidence for the clinical application of ESWT after autologous nerve transplantation as a novel non-invasive method.READ MORE
Depressive Symptoms Related to Biological Markers of Immune Functioning among Young People with HIVPoster
Youth living with HIV (YLWH) are at risk for depression. This study aimed to identify trends in depressive symptoms for YLWH in a specialty-care clinic and follow up clinical treatment procedures.READ MORE
An Emerging Phenotype of Partial RAG 1/2 Deficiency Among Young Children with Autoimmunity and Viral InfectionsPoster
We describe the natural history of a cohort of 12 patients with confirmed partial RAG1/2 mutations and autoimmunity at a young age. We were seeking the link between viral infections and autoimmunity and tested candidate biomarkers that may reflect the underlying RAG1/2 protein deficiency.READ MORE
Comments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.Biopharma Cell Science Diagnostics Drug Discovery Informatics & Automation Proteomics & Metabolomics
To personalize the content you see on Technology Networks homepage, Log In or Subscribe for FreeLOGIN SUBSCRIBE FOR FREE